Cyclacel Pharmaceuticals (Preferred)

YTD

ALL

Why Robinhood?

You can watch CYCCP and buy or sell other stocks, options, and ETFs commission-free!

About CYCCP

Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases.

CEO

Spiro Rombotis

CEOSpiro Rombotis

Employees

—

Employees—

Headquarters

Berkeley Heights, New Jersey

HeadquartersBerkeley Heights, New Jersey

Founded

1996

Founded1996

Employees

—

Employees—

CYCCP Key Statistics

Market cap

2.43M

Market cap2.43M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

4.30K

Average volume4.30K

High today

—

High today—

Low today

—

Low today—

Open price

$7.50

Open price$7.50

Volume

0.00

Volume0.00

52 Week high

$22.20

52 Week high$22.20

52 Week low

$5.25

52 Week low$5.25

CYCCP News

TipRanks 2d

Cyclacel Pharmaceuticals to sell 4.97M shares at $1.61 in private placement

Cyclacel Pharmaceuticals has entered into definitive agreements for the purchase and sale of an aggregate of 4,968,945 shares of common stock, series A warrants...